MetaMarker: A pipeline for de novo discovery of novel metagenomic biomarkers

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Summary: We present MetaMarker, a pipeline for discovering metagenomic biomarkers from whole-metagenome sequencing samples. Different from existing methods, MetaMarker is based on a de novo approach that does not require mapping raw reads to a reference database. We applied MetaMarker on whole-metagenome sequencing of colorectal cancer (CRC) stool samples from France to discover CRC specific metagenomic biomarkers. We showed robustness of the discovered biomarkers by validating in independent samples from Hong Kong, Austria, Germany and Denmark. We further demonstrated these biomarkers could be used to build a machine learning classifier for CRC prediction. Availability and implementation: MetaMarker is freely available at under GPLv3 license. Supplementary information: Supplementary data are available at Bioinformatics online.

Original languageEnglish (US)
Pages (from-to)3812-3814
Number of pages3
Issue number19
StatePublished - Oct 1 2019

ASJC Scopus subject areas

  • Statistics and Probability
  • Biochemistry
  • Molecular Biology
  • Computer Science Applications
  • Computational Theory and Mathematics
  • Computational Mathematics


Dive into the research topics of 'MetaMarker: A pipeline for de novo discovery of novel metagenomic biomarkers'. Together they form a unique fingerprint.

Cite this